Skip to content

Observation of the Clinical Efficacy of Transcutaneous Acupoint Electric Stimulation in the Treatment of Postoperative Cough in Lung Cancer

Transcutaneous Acupoint Electric Stimulation in the Treatment of Postoperative Cough in Lung Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084639
Enrollment
Unknown
Registered
2024-05-22
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cough in Lung Cancer

Interventions

Sham transcutaneous acupoint electrical stimulation group:Sham transcutaneous acupoint electrical stimulation

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) persons aged 18-80 years; (2) general anesthesia and thoracoscopic radical resection of lung cancer or radical resection of lung cancer with lymphadenectomy; (3) primary lung cancer was confirmed by postoperative pathology, without preoperative chemoradiotherapy, without obstruction and distant metastasis; (4) the duration of dry cough was =2 weeks after lung operation; (5) conscious and able to express their views clearly and voluntarily sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients diagnosed with acute respiratory disease within one month; (2) Patients diagnosed with pneumonia through chest X-rays; (3) Patients with a history of asthma or tuberculosis; (4) Patients with uncontrolled hyperthyroidism, severe hypertension, heart disease, systemic infections, coagulation disorders (hypercoagulability or bleeding tendency), and other severe systemic diseases; (5) Patients who have used steroid medications in the past 3 months; (6) Patients who have taken angiotensin-converting enzyme inhibitors (ACE inhibitors) in the past 6 months; (7) Patients with surgical incisions, skin allergies, injuries, or infections in the treatment area; (8) Patients who cannot tolerate transcutaneous acupoint electrical stimulation or who withdraw midway through treatment voluntarily; (9) Patients who are contraindicated for transcutaneous electrical stimulation or have implanted electrophysiological devices; (10) Patients in pregnancy or lactation period.

Design outcomes

Primary

MeasureTime frame
Leicester Cough Questionnaire in Mandarin Chinese (LCQ-MC);

Secondary

MeasureTime frame
Visual analog scale (VAS);Cough symptom score (CSS);Patient's overall assessment of efficacy;

Countries

China

Contacts

Public ContactFanming Kong

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

kongfanming08@163.com+86 136 5212 3653

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026